475 Pill - yellow oval, 20mm
Pill with imprint 475 is Yellow, Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Sun Pharma Global FZE.
Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 475
Imatinib Mesylate
- Imprint
- 475
- Strength
- 400 mg
- Color
- Yellow
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharma Global FZE
- National Drug Code (NDC)
- 47335-0475
- Inactive Ingredients
-
microcrystalline cellulose,
mannitol,
copovidone,
crospovidone,
magnesium stearate,
hypromelloses,
ferric oxide yellow,
polyethylene glycol,
titanium dioxide,
FD&C Yellow No. 6,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "475"
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
